Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ergoloid-mesylates
2. Ergoloid_mesylate
3. Chebi:181460
4. Nicotinebi-l-(+)-tartrate
5. 12'-hydroxy-2'-isopropyl-3',6',18-trioxo-5'-tert-pentyl-9,10-dihydroergotaman #
6. N-[2-hydroxy-7-(2-methylbutan-2-yl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-g]quinoline-9-carboxamide
Molecular Weight | 591.7 g/mol |
---|---|
Molecular Formula | C33H45N5O5 |
XLogP3 | 3.5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 591.34206955 g/mol |
Monoisotopic Mass | 591.34206955 g/mol |
Topological Polar Surface Area | 118 Ų |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Complexity | 1180 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 7 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
68
PharmaCompass offers a list of Dihydroergotoxine Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydroergotoxine Mesylate manufacturer or Dihydroergotoxine Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydroergotoxine Mesylate manufacturer or Dihydroergotoxine Mesylate supplier.
PharmaCompass also assists you with knowing the Dihydroergotoxine Mesylate API Price utilized in the formulation of products. Dihydroergotoxine Mesylate API Price is not always fixed or binding as the Dihydroergotoxine Mesylate Price is obtained through a variety of data sources. The Dihydroergotoxine Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hydrogenated Ergot Alkaloids manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydrogenated Ergot Alkaloids, including repackagers and relabelers. The FDA regulates Hydrogenated Ergot Alkaloids manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydrogenated Ergot Alkaloids API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydrogenated Ergot Alkaloids manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydrogenated Ergot Alkaloids supplier is an individual or a company that provides Hydrogenated Ergot Alkaloids active pharmaceutical ingredient (API) or Hydrogenated Ergot Alkaloids finished formulations upon request. The Hydrogenated Ergot Alkaloids suppliers may include Hydrogenated Ergot Alkaloids API manufacturers, exporters, distributors and traders.
click here to find a list of Hydrogenated Ergot Alkaloids suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hydrogenated Ergot Alkaloids DMF (Drug Master File) is a document detailing the whole manufacturing process of Hydrogenated Ergot Alkaloids active pharmaceutical ingredient (API) in detail. Different forms of Hydrogenated Ergot Alkaloids DMFs exist exist since differing nations have different regulations, such as Hydrogenated Ergot Alkaloids USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hydrogenated Ergot Alkaloids DMF submitted to regulatory agencies in the US is known as a USDMF. Hydrogenated Ergot Alkaloids USDMF includes data on Hydrogenated Ergot Alkaloids's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hydrogenated Ergot Alkaloids USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hydrogenated Ergot Alkaloids suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydrogenated Ergot Alkaloids as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hydrogenated Ergot Alkaloids API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hydrogenated Ergot Alkaloids as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hydrogenated Ergot Alkaloids and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydrogenated Ergot Alkaloids NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hydrogenated Ergot Alkaloids suppliers with NDC on PharmaCompass.
Hydrogenated Ergot Alkaloids Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydrogenated Ergot Alkaloids GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydrogenated Ergot Alkaloids GMP manufacturer or Hydrogenated Ergot Alkaloids GMP API supplier for your needs.
A Hydrogenated Ergot Alkaloids CoA (Certificate of Analysis) is a formal document that attests to Hydrogenated Ergot Alkaloids's compliance with Hydrogenated Ergot Alkaloids specifications and serves as a tool for batch-level quality control.
Hydrogenated Ergot Alkaloids CoA mostly includes findings from lab analyses of a specific batch. For each Hydrogenated Ergot Alkaloids CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydrogenated Ergot Alkaloids may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydrogenated Ergot Alkaloids EP), Hydrogenated Ergot Alkaloids JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydrogenated Ergot Alkaloids USP).